Pharmaceutical Drug Delivery Market Analysis

Pharmaceutical Drug Delivery Market Analysis

Pharmaceutical drug delivery market share from the injectable segment is expected to witness a 7.4% CAGR from 2023 to 2032. There are two types of injectable drug delivery systems: traditional and self-injecting. These devices have gained popularity during the COVID-19 pandemic for making vaccines and is continued to be used to treat conditions like diabetes, cancer, and cardiovascular disease. With the rising number of chronic diseases, the demand for these products will increase worldwide. Pharmaceutical companies are actively expanding their manufacturing capacity to boost the production of injectable drug delivery products. For instance, in October 2022, Eisai launched a new injectable drug delivery facility worth USD 69 million. The company built a research building for the development of new products in the segment.
 

Pharmaceutical drug delivery market share from the infectious diseases segment is predicted to reach more than USD 555 billion by 2032. Worldwide, the prevalence of infectious diseases including SARS, swine flu, TB, and others is rising. Oral or injectable drug delivery techniques are majorly used for the effective treatment of infectious disorders. Climate change and viruses like COVID-19 are increasing the burden of healthcare infrastructure, driving the need for effective drug delivery solutions. As per the CDC, the West Nile virus, Lyme disease, and valley fever are a few examples of infectious diseases that have spread over the years.
 

Pharmaceutical drug delivery market share from the hospitals segment is expected to reach over USD 1.8 trillion by 2032. This growth will be accelerated by the large patient population visiting hospitals for a range of diseases. Hospitals also provide a wide range of medical services to patients, which accelerates market growth. The advanced infrastructure and medical devices present in hospitals attract more patients. The development of cutting-edge technologies and the presence of highly skilled professionals will influence market growth over the coming years.
 

North America pharmaceutical drug delivery market share was nearly 49% in 2022. Alcohol consumption, smoking, and sedentary behavior are all contributing to an increase in cases of diseases, which will support market expansion. Additionally, the region is home to a significant number of well-known pharmaceutical brands. Multiple hospitals and other healthcare facilities are in abundance in the region. Furthermore, high healthcare expenditures and expanding government initiatives to support improvement in healthcare sector is expected to endorse pharmaceutical drug delivery companies in the region.